Analysts are bullish on these following companies: Lovisa Holdings, DTI Group, Volpara Health Technologies. These companies are relatively strong financially, and have a great outlook in terms of profits and cash flow. The list I’ve put together below are of stocks that compare favourably on all criteria, which potentially makes them a good investment if you believe the growth has not already been reflected in the share price.
Lovisa Holdings Limited (ASX:LOV)
Lovisa Holdings Limited operates as a fashion jewelry retailer. Started in 2010, and run by CEO Steven Doyle, the company employs 855 people and with the stock’s market cap sitting at AUD A$704.66M, it comes under the small-cap stocks category.
LOV’s projected future profit growth is a robust 20.27%, with an underlying 28.53% growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 72.97%. LOV’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about LOV? I recommend researching its fundamentals here.
DTI Group Limited (ASX:DTI)
DTI Group Limited develops, manufactures, and supplies integrated surveillance, passenger communication, and fleet management solutions for mass transit industrial and other related markets worldwide. DTI Group was formed in 1995 and has a market cap of AUD A$17.10M, putting it in the small-cap stocks category.
DTI’s projected future profit growth is a robust 35.02%, with an underlying 74.57% growth from its revenues expected over the upcoming years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 10.98%. DTI ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper.
Considering DTI as a potential investment? Check out its fundamental factors here.
Volpara Health Technologies Limited (ASX:VHT)
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. Formed in 2009, and currently headed by CEO Ralph Highnam, the company provides employment to 39 people and with the company’s market cap sitting at AUD A$88.75M, it falls under the small-cap stocks category.